Clinical Trial Update: Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluated the effect of the beta-blocker bisoprolol on glycemic levels in adults with type 2 diabetes and suboptimal blood pressure contr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bisoprolol (Bisoprolol)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Hypertension, Diabetes Mellitus, Type II | Phase 4 | Status: COMPLETED | Results posted: 2014-07-04